CIK 0001582554
- Non-accelerated filer
- Smaller reporting company
Matinas BioPharma Holdings, Inc.
Sign in to watch- Ticker
- MTNB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463011414
- Phone
- +1 908-484-8805
- Business address
- 1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 11,673 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 20,725 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 20,000 shares at $0.83 ($16,600)
- 4 Grant or award Director acquired 20,537 shares (grant or award)
- 4 Other acquisition Director acquired 30,000 shares (other)
- 4 Other acquisition President and CEO acquired 4,500 shares (other)
- 4 Other acquisition Director acquired 1,800 shares (other)
- 4 Other acquisition Director acquired 3,600 shares (other)
- 4 Other acquisition Chief Scientific Officer acquired 3,000 shares (other)
Page 5 of 12 · 232 filings